I started preparing for pregnancy, my husband and I took tests and my tests were not very good, and the doctor advised me to drink these sachets for several months. at first I didn't think that they would help me, but after some time I felt better:) I drank them for 4 months - I'm pregnant! Thank you very much
FertylOva – Improving Ovulation and Restoring Fertility
Complex for restoration of reproduction
FertylOva – Improving Ovulation and Restoring Fertility
Complex for restoration of reproduction
Article:10202
from 3 pcs 2 935 ₴
3 090 ₴
Complex for normalizing the menstrual cycle and improving ovulation.
Contributes to the restoration of hormonal balance, normalization of ovulation and the menstrual cycle, especially in PCOS.
Improving fertility
Healthy pregnancy
Made in Great Britain
Specialization Reproduction
Clinically proven
Made in Great Britain
Description
Compound
Reviews [2]
- About FertilOva®
- FertilOv® components contribute to:
- Biological effect of components FertilOva®
- Why exactly FertilOva® plus
- Recommendations for use
- Method of use
- Reception duration
- Release form
About FertilOva®
FertilOva is a complex for normalizing the menstrual cycle and improving ovulation.
According to statistics, about 15% of couples have difficulties conceiving.
Even if the woman is completely healthy, the chance become pregnant during one menstrual cycle is only 25%.
Many things affect a woman's ability to get pregnant factors, but one of the most common causes of female infertility is polycystic ovary syndrome (PCOS).
Being the cause of more than half of infertility cases of endocrine origin (50-75%), PCOS also increases risk miscarriage.
FertilOva supports women who may have difficulty conceiving, as it can promote regular ovulation work ovaries, regular menstrual cycles and can help improve egg quality.
FertilOva was designed for women suffering from polycystic ovary syndrome (PCOS).
According to statistics, about 15% of couples have difficulties conceiving.
Even if the woman is completely healthy, the chance become pregnant during one menstrual cycle is only 25%.
Many things affect a woman's ability to get pregnant factors, but one of the most common causes of female infertility is polycystic ovary syndrome (PCOS).
Being the cause of more than half of infertility cases of endocrine origin (50-75%), PCOS also increases risk miscarriage.
FertilOva supports women who may have difficulty conceiving, as it can promote regular ovulation work ovaries, regular menstrual cycles and can help improve egg quality.
FertilOva was designed for women suffering from polycystic ovary syndrome (PCOS).
FertilOv® components contribute to:
At the stage of preparation for pregnancy:
- Normalization of a woman's hormonal background;
- Increasing the number of ovulatory cycles and improving the quality of eggs2,3;
- Increasing the chances of successful conception.
- Reducing the risk of developing gestational diabetes in pregnant women1,4;
- Reducing the risk of developing neural tube defects in the fetus.
- Stimulation of ovulation;
- Reducing acne manifestations;
- Normalization of weight.
- Decreasing the total amount of gonadotropins5;
- Improving the process of implantation of a fertilized egg.
Biological effect of components
FertilOva®
Myo-inositolMyo-inositol, the main ingredient of FertilOva, is present in every living cell and
performs many important functions.
One important role is involvement in the insulin messenger system (1).
Myoinositol is involved in the insulin signal from the insulin receptor, which is especially important for patients with insulin resistance.
It also helps normalize hormone levels, which in turn helps regular menstrual cycles and normal ovulation function.
Studies show that taking inositol helps improve ovarian function and metabolic disorders, associated with PCOS.
Between 65% and 80% of PCOS patients have insulin resistance and it is believed that this the condition contributes to a number of other problems, such as metabolic syndrome, hormonal imbalance, and androgenic symptoms and gestational diabetes.
Patients with PCOS have a higher than usual risk of developing metabolic syndrome syndrome; a combination of conditions including weight gain, type 2 diabetes, and dyslipidemia.
Approx one-third to one-half of all women and adolescent girls with PCOS have metabolic syndrome.
Newly the published RCOG green top guideline advises doctors to inform patients with PCOS about the following long-term health effects.
Such patients have significant long-term health risks, and evidence the use of FertilOva ingredients in these patients is convincing.
Folic acid Folic acid, another ingredient in FertilOva™, is a water-soluble vitamin B.
Folic Acid Plays a Key Role in Protein Amino Acid Metabolism and Chromosome Fusion and Repair and therefore is a key factor for normal cell division and tissue growth.
One important role is involvement in the insulin messenger system (1).
Myoinositol is involved in the insulin signal from the insulin receptor, which is especially important for patients with insulin resistance.
It also helps normalize hormone levels, which in turn helps regular menstrual cycles and normal ovulation function.
Studies show that taking inositol helps improve ovarian function and metabolic disorders, associated with PCOS.
Between 65% and 80% of PCOS patients have insulin resistance and it is believed that this the condition contributes to a number of other problems, such as metabolic syndrome, hormonal imbalance, and androgenic symptoms and gestational diabetes.
Patients with PCOS have a higher than usual risk of developing metabolic syndrome syndrome; a combination of conditions including weight gain, type 2 diabetes, and dyslipidemia.
Approx one-third to one-half of all women and adolescent girls with PCOS have metabolic syndrome.
Newly the published RCOG green top guideline advises doctors to inform patients with PCOS about the following long-term health effects.
Such patients have significant long-term health risks, and evidence the use of FertilOva ingredients in these patients is convincing.
Folic acid Folic acid, another ingredient in FertilOva™, is a water-soluble vitamin B.
Folic Acid Plays a Key Role in Protein Amino Acid Metabolism and Chromosome Fusion and Repair and therefore is a key factor for normal cell division and tissue growth.
Why exactly FertilOva® plus
Recommendations for use
Recommended for the diet to improve reproductive function in women and maintain normal
hormone balance; to promote the normalization of ovulation and improve the state of germ cells; for general
strengthening the body.
Method of use
1-2 sachets per day.
Dissolve the contents of the sachet in 200 ml of warm (not hot) water, mix thoroughly and drink immediately after cooking.
It has an orange taste.
Dissolve the contents of the sachet in 200 ml of warm (not hot) water, mix thoroughly and drink immediately after cooking.
It has an orange taste.
Reception duration
From 3 to 6 months.
In the future, the term of use should be agreed with the doctor.
In the future, the term of use should be agreed with the doctor.
Release form
30 or 60 sachets.
| Composite | in 1 sachet |
|---|---|
| Myo-inositol | 2000 mg |
| Folic acid | 200 mcg |
Method of application:
1-2 sachets per day. Dissolve the contents of the sachet in 200 ml of warm (not hot) water, mix thoroughly and drink
immediately after cooking. It has an orange taste.
Duration of reception:
From 3 to 6 months. In the future, the term of use should be agreed with the doctor.
Form of issue:
30 or 60 sachets.
I drank it for 3 months, the drug was very easily absorbed, I liked the shape of the sachet. the test results have improved, thank you!!!
Thank you for your feedback!
Payment methods
Delivery methods
Nova Poshta
Pickup
Link:
- Corrado F. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011 Aug; 28(8) 972-5
- Costantino D. Metabolic and hormonal effects of myo-inositol in women with PCOS: a double-blind trial. European Review for Medical and Pharmacological Sciences. 2009; 13(2);105-10.
- Gerli S. Randomized double-blind, placebo-controlled study: effects of myo-inositol on ovarian function and metabolic factors in women with COCs. European Review of Medical and Pharmacological Sciences. 2007; 11(5); 347-354
- Werner EF. Potencial Role for Myoinositol in the Prevention of Gestational Diabetes Mellitus / American Journal of Perinatology / 2016; 33(13); 1236-1241
- Franco L. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reproductive Biology and Endocrinology. 2012; 10:52
